Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bldg 10, Clinical Research Center, 10 Center Drive, Bethesda, MD 20892-1540, USA.
J Clin Psychiatry. 2011 Jan;72(1):60-5. doi: 10.4088/JCP.09m05256gry. Epub 2010 Jun 29.
Behaviorally based therapies for the treatment of perpetrators who initiate intimate partner violence (IPV) have generally shown minimal therapeutic efficacy. To explore a new treatment approach for IPV, we examined the effects of a selective serotonin reuptake inhibitor on the irritability subscale score of the Modified Overt Aggression Scale. This score served as a surrogate marker for the anger and physical aggression that characterize perpetrators of IPV.
A 12-week, double-blind, randomized, placebo-controlled intervention study employing fluoxetine, alcohol treatment, and cognitive-behavioral therapy was performed. Sixty (46 men) non-court-mandated, DSM-IV-diagnosed alcoholic perpetrators of IPV with a history of at least 2 episodes of IPV in the year prior to participation in the study were evaluated. The primary outcome measure was the score on the irritability subscale of the Modified Overt Aggression Scale. Secondary measures included anxiety, depression, and ratings by the perpetrator's spouse/significant other. The study was conducted from January 2002 through December 2007.
A repeated-measures analysis of variance using the irritability subscale scores obtained from perpetrators who completed the 12-week study (n = 24) showed a significant drug effect (F(1,21) = 12.09, P = .002). Last observation carried forward (F(1,32) = 4.24, P = .048) as well as intent-to-treat analysis (F(1,54) = 5.0, P = .034) also showed a significant drug effect. Spouses'/significant others' physical and nonphysical Partner Abuse Scale ratings showed a significant reduction of abuse over time (F(1,11) = 10.2, P = .009 and F(1,11) = 24.2, P = .0005, respectively).
This is the first controlled study to show that a pharmacologic intervention employing a selective serotonin reuptake inhibitor, in conjunction with alcohol treatment and cognitive-behavioral therapy, can reduce measures of anger and physical aggression in alcoholic perpetrators of IPV.
针对发起亲密伴侣暴力(IPV)的加害者的行为治疗方法通常显示出最小的治疗效果。为了探索一种新的 IPV 治疗方法,我们研究了选择性 5-羟色胺再摄取抑制剂对改良显性攻击量表激惹分量表评分的影响。该评分可作为表现 IPV 加害者愤怒和身体攻击特征的替代指标。
进行了一项为期 12 周、双盲、随机、安慰剂对照的干预研究,使用氟西汀、酒精治疗和认知行为疗法。共评估了 60 名(46 名男性)非法庭强制、DSM-IV 诊断的酒精性 IPV 加害者,他们在参与研究前一年至少有 2 次 IPV 发作史。主要结局指标为改良显性攻击量表激惹分量表的评分。次要指标包括焦虑、抑郁和加害者配偶/重要他人的评分。研究于 2002 年 1 月至 2007 年 12 月进行。
对完成 12 周研究的加害者(n=24)的激惹分量表评分进行重复测量方差分析显示,药物效应显著(F(1,21)=12.09,P=.002)。末次观测结转(F(1,32)=4.24,P=.048)和意向治疗分析(F(1,54)=5.0,P=.034)也显示药物效应显著。配偶/重要他人的身体和非身体伴侣虐待量表评分显示虐待行为随时间显著减少(F(1,11)=10.2,P=.009 和 F(1,11)=24.2,P=.0005)。
这是第一项对照研究,表明采用选择性 5-羟色胺再摄取抑制剂、酒精治疗和认知行为疗法的药物干预可以降低 IPV 酒精性加害者的愤怒和身体攻击行为的测量值。